RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways.

J Genet Genomics

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China. Electronic address:

Published: July 2021

AI Article Synopsis

  • RNA binding motif proteins (RBMs) have a role in various cancers, but RBM47 is found to be particularly important in nasopharyngeal carcinoma (NPC), showing increased levels in tumor samples compared to controls.
  • High expression of RBM47 correlates with poor patient outcomes and promotes cancer cell growth by regulating genes like BCAT1 and enhancing alternative splicing of pre-mRNA.
  • The study suggests that RBM47, in collaboration with another protein called hnRNPM, could serve as both a prognostic indicator and a potential target for NPC treatment.

Article Abstract

RNA binding motif proteins (RBMs) have been widely implicated in the tumorigenesis of multiple human cancers but scarcely studied in nasopharyngeal carcinoma (NPC). Here, we compare the mRNA levels of 29 RBMs between 87 NPC and 10 control samples. We find that RBM47 is frequently upregulated in NPC specimens, and its high expression is associated with the poor prognosis of patients with NPC. Biological experiments show that RBM47 plays an oncogenic role in NPC cells. Mechanically, RBM47 binds to the promoter and regulates the transcription of BCAT1, and its overexpression partially rescues the inhibitory effects of RBM47-knockdown on NPC cells. Moreover, transcriptome analysis reveals that RBM47 regulates alternative splicing of pre-mRNA, including those cancer-related, to a large extent in NPC cells. Furthermore, RBM47 binds to hnRNPM and cooperatively regulates multiple splicing events in NPC cells. In addition, we find that knockdown of hnRNPM inhibits proliferation and migration of NPC cells. Our study, taken together, shows that RBM47 promotes the progression of NPC through multiple pathways, acting as a transcriptional factor and a modulator of alternative splicing in cooperation with hnRNPM. Our study also highlights that RBM47 and hnRNPM could be prognostic factors and potential therapeutic targets for NPC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgg.2021.05.006DOI Listing

Publication Analysis

Top Keywords

npc cells
20
npc
11
rbm47
8
rbm47 promotes
8
nasopharyngeal carcinoma
8
multiple pathways
8
rbm47 binds
8
alternative splicing
8
cells
5
rna-binding motif
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!